Blood marker test for solid tumor cancer
Part of Cancer clinical trials.
This study is looking at a blood marker (a type of chemical change in cells) to see if it can help predict how solid tumor cancers will behave. If you have a solid tumor cancer, this research might help doctors understand your condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed diagnosis of a solid tumor cancer (like lung, breast, or colon cancer) and are about to get cancer treatment.
- You are not pregnant.
- You do not have serious mental illness or communication problems that would make it hard to participate.
- You may be a healthy person without cancer (for the control group).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study looks at how blood can help us better understand solid cancers. You may be able to join if you’re an adult with solid cancer and your usual care already involves taking blood, and you can safely provide samples for the study.
This study looks for new blood (serum) markers that may show whether anti-cancer therapy is working. If you have cancer or possible cancer and can safely take part, your blood may be used to monitor treatment response over time.
This study uses a blood test (liquid biopsy) to find genetic changes in advanced solid tumors. It may help doctors choose the right treatment and monitor how well it works over time.
This study looks at tumor tissue and/or blood “biomarkers” to help predict whether a solid tumor will respond well to radiation therapy. It may help doctors choose more effective treatments in the future, and it may guide your care during radiotherapy if you qualify.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.